|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 659.50 GBX | +1.54% |
|
+7.85% | +42.13% |
| 05/05 | FTSE 100 pulled down by banks amid Iran war worry | AN |
| 29/04 | WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach | AN |
| Fiscal Period: April | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 22Cr | 31Cr | 24Cr | 10Cr | 19Cr | |||||
Total Cash And Short Term Investments | 22Cr | 31Cr | 24Cr | 10Cr | 19Cr | |||||
Accounts Receivable, Total | 3.44Cr | 2.93Cr | 1.84Cr | 3.46Cr | 3.84Cr | |||||
Other Receivables | 2L | 3L | 4L | 4L | 5L | |||||
Total Receivables | 3.46Cr | 2.96Cr | 1.88Cr | 3.5Cr | 3.89Cr | |||||
Prepaid Expenses | 16.82L | 17.41L | 22.15L | 29.42L | 13.85L | |||||
Other Current Assets, Total | 40.9L | 64.79L | 25.71L | 95.57L | 1.3Cr | |||||
Total Current Assets | 26Cr | 35Cr | 26Cr | 15Cr | 24Cr | |||||
Long-term Investments | 324.3Cr | 281.11Cr | 264.02Cr | 371.38Cr | 366.49Cr | |||||
Total Assets | 349.96Cr | 316.03Cr | 290.28Cr | 386.43Cr | 390.7Cr | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 2.92Cr | 4.94Cr | 1.93Cr | 68.85L | 1.77Cr | |||||
Accrued Expenses, Total | 70.89L | 67.34L | 22.13L | 28.57L | 28.59L | |||||
Short-term Borrowings | 34.73L | - | - | 4L | 10.46L | |||||
Current Portion of Long-Term Debt | - | 5.2Cr | - | 4.8Cr | - | |||||
Other Current Liabilities | - | 11.31L | 23.44L | 15.53L | 17.98L | |||||
Total Current Liabilities | 3.97Cr | 11Cr | 2.38Cr | 5.98Cr | 2.34Cr | |||||
Long-Term Debt | 5.11Cr | - | 5.08Cr | - | 7.87Cr | |||||
Total Liabilities | 9.08Cr | 11Cr | 7.47Cr | 5.98Cr | 10Cr | |||||
Common Stock, Total | 3.43Cr | 3.43Cr | 3.43Cr | 3.43Cr | 3.43Cr | |||||
Additional Paid In Capital | 22Cr | 22Cr | 22Cr | 22Cr | 22Cr | |||||
Retained Earnings | 313.07Cr | 277.29Cr | 255.01Cr | 352.65Cr | 352.68Cr | |||||
Comprehensive Income and Other | 2.03Cr | 2.03Cr | 2.03Cr | 2.03Cr | 2.03Cr | |||||
Total Common Equity | 340.88Cr | 305.1Cr | 282.81Cr | 380.45Cr | 380.49Cr | |||||
Total Equity | 340.88Cr | 305.1Cr | 282.81Cr | 380.45Cr | 380.49Cr | |||||
Total Liabilities And Equity | 349.96Cr | 316.03Cr | 290.28Cr | 386.43Cr | 390.7Cr | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 136.01Cr | 130.88Cr | 125.06Cr | 119.66Cr | 115.8Cr | |||||
ECS Total Common Shares Outstanding | 136.54Cr | 132.36Cr | 126.29Cr | 120.62Cr | 117Cr | |||||
Book Value / Share | 2.5 | 2.31 | 2.24 | 3.15 | 3.25 | |||||
Tangible Book Value | 340.88Cr | 305.1Cr | 282.81Cr | 380.45Cr | 380.49Cr | |||||
Tangible Book Value Per Share | 2.5 | 2.31 | 2.24 | 3.15 | 3.25 | |||||
Total Debt | 5.46Cr | 5.2Cr | 5.08Cr | 4.85Cr | 7.98Cr | |||||
Net Debt | -16Cr | -26Cr | -19Cr | -5.46Cr | -11Cr | |||||
Account Code - Inventory Valuation | 3 | 3 | - | 3 | 3 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















